Morgan Drake
Family · Weatherford, TXNPI 1285476861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 10.0% — the pattern of someone who eats at a lot of different presentations.
Across 75 payments — averaging $26.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$199
- Johnson & Johnson$185
- Lilly USA, LLC$169
- Puma Biotechnology, Inc.$141
- Tempus AI, Inc$125
- Blueprint Medicines Corporation$119
- plus $1K from 31 others
What the payments were for
- Food & beverage$1,89895%
- Education$925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $199 |
| Johnson & Johnson | 4 | $185 |
| Lilly USA, LLC | 5 | $169 |
| Puma Biotechnology, Inc. | 2 | $141 |
| Tempus AI, Inc | 2 | $125 |
| Blueprint Medicines Corporation | 1 | $119 |
| Novartis | 5 | $97 |
| AbbVie | 3 | $78 |
| Sobi, Inc | 3 | $59 |
| Beone Medicines USA, Inc. | 3 | $57 |
| Jazz Pharmaceuticals Inc. | 2 | $52 |
| EMD Serono, Inc. | 2 | $50 |
| Geron Corporation | 2 | $47 |
| Sanofi | 2 | $46 |
| Incyte Corporation | 2 | $44 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Taiho Oncology, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Caris MPI, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Genentech USA, Inc. | 2 | $29 |
| Eisai Inc. | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $24 |
| Genmab U.S., Inc. | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Immunocore Limited | 1 | $21 |
| Gilead | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $16 |
| Bayer | 1 | $16 |
| GSK | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Acrotech Biopharma Inc. | 1 | $14 |
| Beigene USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,991 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 29 | $311 |
| Ondansetron OdtOndansetron | 24 | $280 |
Paid to pharmacies, not to this prescriber.
Other family in Weatherford
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.